Skip to main content
Clinical Trials/NCT03852056
NCT03852056
Completed
Phase 3

The Clinical Investigation of a New Toothpaste Containing SnF as Compared to Colgate Fluoride Toothpaste in Reducing Plaque and Gingivitis - a Six-month Study in China

Colgate Palmolive1 site in 1 country98 target enrollmentMay 25, 2017

Overview

Phase
Phase 3
Intervention
MFP Fluoride toothpaste
Conditions
Dental Plaque
Sponsor
Colgate Palmolive
Enrollment
98
Locations
1
Primary Endpoint
Dental Plaque Scores
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The objective of this study is to evaluate the clinical efficacy of a new toothpaste containing stannous fluoride (SnF) as compared to Colgate Fluoride Toothpaste in reducing gingivitis and dental plaque.

Detailed Description

This is a 6 month, take home, tooth brushing research study to evaluate a new toothpaste. Qualified subjects will be enrolled and randomized to either one of the two study groups based on their initial Plaque and Gingivitis scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after three and six months of product use. All subjects will be followed for adverse events throughout the study.

Registry
clinicaltrials.gov
Start Date
May 25, 2017
End Date
December 7, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects, ages 18-70, inclusive.
  • Availability for the six-month duration of the clinical research study.
  • Good general health.
  • Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  • Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  • Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
  • Signed Informed Consent Form.

Exclusion Criteria

  • Presence of orthodontic bands.
  • Presence of partial removable dentures.
  • Tumor(s) of the soft or hard tissues of the oral cavity.
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  • Five or more carious lesions requiring immediate restorative treatment.
  • Antibiotic use any time during the one-month period prior to entry into the study.
  • Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • Dental prophylaxis during the past two weeks prior to baseline examinations.
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome.

Arms & Interventions

MFP Fluoride toothpaste

Commercially available, monofluorophosphate (MFP) toothpaste. Fluoride level is 0.76%

Intervention: MFP Fluoride toothpaste

Stannous Fluoride Toothpaste

New toothpaste containing 0.454% stannous fluoride.

Intervention: Stannous fluoride toothpaste

Outcomes

Primary Outcomes

Dental Plaque Scores

Time Frame: 6 month

Quigley-Hein, Turesky Modification Index. Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Gingivitis Scores

Time Frame: 6 months

Loe \& Silness Gingival Index. Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Study Sites (1)

Loading locations...

Similar Trials